192 related articles for article (PubMed ID: 8434385)
1. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of rapamycin and cyclosporine on kidney and heart morphology in a rabbit heterotopic heart transplant model.
Thliveris JA; Solez K; Yatscoff RW
Histol Histopathol; 1995 Apr; 10(2):417-21. PubMed ID: 7599438
[TBL] [Abstract][Full Text] [Related]
3. [Combined rapamycin eye drop in nanometer vector and poly (lactic acid) wafers of cyclosporine A effectively prevents high-risk corneal allograft rejection in rabbits].
Jiang W; Sun HM; Li XR; Yuan XB; Wang YQ; Zhang SX; Tian EJ; Yuan JQ
Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):550-5. PubMed ID: 19957680
[TBL] [Abstract][Full Text] [Related]
4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
5. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
Chen H; Wu J; Xu D; Luo H; Daloze PM
Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
[TBL] [Abstract][Full Text] [Related]
6. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
8. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
Wang ME; Stepkowski SM; Ferraresso M; Kahan BD
Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762
[TBL] [Abstract][Full Text] [Related]
9. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival.
Hamashima T; Stepkowski SM; Chou TC; Kahan BD
Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
12. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat.
DiJoseph JF; Fluhler E; Armstrong J; Sharr M; Sehgal SN
Transplantation; 1996 Oct; 62(8):1109-12. PubMed ID: 8900311
[TBL] [Abstract][Full Text] [Related]
14. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
Yatscoff RW; LeGatt DF; Kneteman NM
Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
[TBL] [Abstract][Full Text] [Related]
16. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
Levy AE; Alexander JW; Babcock GF
Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
[TBL] [Abstract][Full Text] [Related]
17. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat.
Knight RJ; Polokoff EG; Martinelli GP
Transplantation; 1994 Nov; 58(9):1014-20. PubMed ID: 7974728
[TBL] [Abstract][Full Text] [Related]
19. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival.
Boyle MJ; Baghdassarian V; Stepkowski SM; Dumble LJ; Kahan BD
Cell Transplant; 1998; 7(3):247-56. PubMed ID: 9647434
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
